[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369413-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369413-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","disseminated-talaromycosis-in-hiv-negative-patients-with-lung-cancer-a-rare-case-report-and-literature-review","Disseminated talaromycosis in HIV-negative patients with lung cancer - a rare case report and literature review","","Talaromycosis has long been linked to HIV/AIDS, but effective HIV control has led to a growing number of HIV-negative cases, often with immunosuppressive conditions such as tumors. This report addresses a gap in clinical knowledge by focusing on a rare presentation in an HIV-negative patient with lung cancer. A lung squamous cell carcinoma case combined with Talaromyces marneffei infection was diagnosed using sputum cytology and blood/CSF metagenomics sequencing. The patient received antifungal therapy only and died from multi-organ failure and sepsis. The study emphasizes the need for timely HIV testing and AIGA evaluation, multiple-site cultures, mNGS for diagnosis, and biopsies to confirm concurrent lung cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/disseminated-talaromycosis-in-hiv-negative-patients-with-lung-cancer-a-rare-case-report-and-literature-review/369413/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/disseminated-talaromycosis-in-hiv-negative-patients-with-lung-cancer-a-rare-case-report-and-literature-review/369413.png","ImageObject",300,407,{"name":42,"@type":43},"Jacob","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is talaromycosis in HIV-negative patients with lung cancer clinically noteworthy?","Question",{"text":63,"@type":64},"With improved HIV control, more talaromycosis occurs without HIV, but lung-cancer co-occurrence remains rare and has limited comprehensive reviews, creating gaps in clinical guidance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the lung cancer and talaromycosis diagnosis established in the reported case?",{"text":68,"@type":64},"Diagnosis was supported by sputum cytology and blood/CSF metagenomics next-generation sequencing (mNGS), together with clinical and imaging findings.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic and screening recommendations does the report highlight?",{"text":72,"@type":64},"For suspected pulmonary fungal infection, it is crucial to test for HIV and anti-IFN-γ autoantibodies (AIGA), perform multiple-site cultures, use mNGS to improve accuracy, and use appropriate biopsies to confirm lung cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369413,1790197958,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","He et al. BMC Infectious Diseases (2025) 25:601 [https://doi.org/10.1186/s12879-025-10985-5](https://doi.org/10.1186/s12879-025-10985-5)  \nBMC Infectious Diseases  \n CASE REPORT Open Access  \nDisseminated talaromycosis in HIV-negative patients with lung cancer: a rare case report and literature review  \nHaiyang He1†, Liuyang Cai1†, Xiaochun Xue2†, Kangmei Zhang3, Qin Huang3, Anyu Qiu3, Haiyin Fan3, Yusong Lin 1, Bin Xu3* and Weihua Pan 1*  \nAbstract  \nBackground Talaromycosis has long been considered to be exclusively associated with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) . In recent years, with effective control measures for HIV, the number oftalaromycosis patients without HIV infection has been increasing annually. All of these patients have various immunosuppressive factors, including tumors. However, we find that talaromycosis among HIV-negative lung cancer patients remains a rarity and is without comprehensive reviews, contributing to significant gaps in clinical knowledge.  \nCase presentation We report a case of lung squamous cell carcinoma combined with Talaromyces marneffei  \n( T.marneffei) infection in an HIV-negative patient. The patient, a male with a history of long-term smoking, presented with recurrent fever and cough. Chest computed tomography (CT) scans revealed pleural effusion and nodules. The patient was diagnosed with lung squamous cell carcinoma and talaromycosis through sputum cytology and blood/ cerebrospinal fluid metagenomics next-generation sequencing (mNGS) . The patient underwent only antifungal therapy and succumbed to respiratory failure, liver and kidney failure, and sepsis in January 2024, before receiving any anti-tumor therapy.  \nConclusion The mortality rate oftalaromycosis combined with lung cancer is extremely high. Therefore, regardless of whether patients have a history of travel to endemic areas of T. marneffei infection, it is crucial to test for HIV and anti-IFN-γ autoantibodies (AIGA) in patients suspected of having a pulmonary fungal infection, as well as conducting multiple cultures of specimens from different sites and utilizing mNGS to enhance diagnostic accuracy. Additionally, it is essential to perform biopsies in various methods from multiple sites to ascertain the presence of lung cancer. With effective control of T. marneffei infection and timely diagnosis and treatment of lung cancer, there can bea significant improvement in patient survival rates.  \nKeywords Talaromyces marneffei, Talaromycosis, Lung cancer, HIV-negative, Non-HIV-infected  \n†Haiyang He, Liuyang Cai and Xiaochun Xue contributed equally to this work.  \n*Correspondence: Bin Xu [xubin1968@126.com](xubin1968@126.com)[ ](xubin1968@126.com)Weihua Pan [panweihua9@sina.com](panweihua9@sina.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licen","cbCaioLwD5AcjFwK","https://ap.wps.com/l/cbCaioLwD5AcjFwK","pdf",1517775,12,"English","# Abstract\n# Introduction\n# Case report","[{\"question\":\"Why is talaromycosis in HIV-negative patients with lung cancer clinically noteworthy?\",\"answer\":\"With improved HIV control, more talaromycosis occurs without HIV, but lung-cancer co-occurrence remains rare and has limited comprehensive reviews, creating gaps in clinical guidance.\"},{\"question\":\"How was the lung cancer and talaromycosis diagnosis established in the reported case?\",\"answer\":\"Diagnosis was supported by sputum cytology and blood/CSF metagenomics next-generation sequencing (mNGS), together with clinical and imaging findings.\"},{\"question\":\"What diagnostic and screening recommendations does the report highlight?\",\"answer\":\"For suspected pulmonary fungal infection, it is crucial to test for HIV and anti-IFN-γ autoantibodies (AIGA), perform multiple-site cultures, use mNGS to improve accuracy, and use appropriate biopsies to confirm lung cancer.\"}]","Disseminated talaromycosis in HIV-negative patients with lung cancer - a rare case report and literature review | PDF",1790182533,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16849dfb270bfbf306344da30a1d87da.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66d46c4bcdc71911caa02be14bb207c3.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91615a1745db3499f60f07499553ca63.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70b1f9615b5cb580bfbf631d19047cd2.webp",980,1301]